caffeine has been researched along with Cardiovascular Stroke in 93 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of high dose caffeine on ventricular arrhythmias was examined in 35 patients with recent myocardial infarctions." | 9.06 | High dose caffeine and ventricular arrhythmias. ( Harris, L; Myers, MG, 1990) |
| "Caffeine (300 mg) was administered to each of 70 patients a mean (+/- standard error of the mean) of 7 +/- 1 days after the onset of acute myocardial infarction to determine its effects on ventricular arrhythmias." | 9.06 | Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction. ( Grant, DM; Harris, L; Leenen, FH; Myers, MG, 1987) |
| "Because of possible side effects of herbal medicines containing ephedrine and guarana-derived caffeine, including increased risk of stroke, myocardial infarction, and sudden death, the Food and Drug Administration recently banned the sale of ephedra-containing products, specifically over-the-counter dietary supplements." | 7.73 | Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. ( Collins, BJ; Dunnick, JK; Foley, JF; Hanlon, P; Howden, R; Murphy, E; Nyska, A; Petranka, J, 2005) |
| "Using microelectrode techniques, we investigated the electrophysiologic effects of cocaine on endocardial canine Purkinje fibers that survived 1 day of myocardial infarction." | 7.69 | Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction. ( Assadi, M; Boutjdir, M; el-Sherif, N, 1995) |
| "The effect of high dose caffeine on ventricular arrhythmias was examined in 35 patients with recent myocardial infarctions." | 5.06 | High dose caffeine and ventricular arrhythmias. ( Harris, L; Myers, MG, 1990) |
| "Caffeine (300 mg) was administered to each of 70 patients a mean (+/- standard error of the mean) of 7 +/- 1 days after the onset of acute myocardial infarction to determine its effects on ventricular arrhythmias." | 5.06 | Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction. ( Grant, DM; Harris, L; Leenen, FH; Myers, MG, 1987) |
| "Physical exertion and caffeine consumption are associated with acute myocardial infarction (MI)." | 3.91 | Immediate risk of myocardial infarction following physical exertion, tea, and coffee: A case-crossover study in Thailand. ( Berhane, HY; Chahal, HS; Gelaye, B; Lohsoonthorn, V; Mostofsky, E; Rattananupong, T; Thomas, C; Wuttithai, N; Wynne, K, 2019) |
| "Myocardial perfusion scintigraphy (MPS) was used to assess adenosine-induced hyperemia in 30 patients before (baseline) and after coffee ingestion (caffeine)." | 3.74 | High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine. ( Anagnostopoulos, C; Donovan, J; Harbinson, M; Loong, CY; Reyes, E; Underwood, SR, 2008) |
| "Because of possible side effects of herbal medicines containing ephedrine and guarana-derived caffeine, including increased risk of stroke, myocardial infarction, and sudden death, the Food and Drug Administration recently banned the sale of ephedra-containing products, specifically over-the-counter dietary supplements." | 3.73 | Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine. ( Collins, BJ; Dunnick, JK; Foley, JF; Hanlon, P; Howden, R; Murphy, E; Nyska, A; Petranka, J, 2005) |
| "Using microelectrode techniques, we investigated the electrophysiologic effects of cocaine on endocardial canine Purkinje fibers that survived 1 day of myocardial infarction." | 3.69 | Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction. ( Assadi, M; Boutjdir, M; el-Sherif, N, 1995) |
| "These findings do not support the hypothesis that coffee or caffeine consumption increases the risk of coronary heart disease or stroke." | 3.68 | Coffee, caffeine, and cardiovascular disease in men. ( Colditz, G; Giovannucci, E; Grobbee, DE; Rimm, EB; Stampfer, M; Willett, W, 1990) |
| "In the course of evaluating the acute effect of caffeine-containing coffee on the risk of myocardial infarction (MI) among women 30-49 years of age, this study noted appreciable differences in coffee consumption among hospital patients admitted for illnesses not known to be related to coffee use." | 3.66 | Case-control studies on the acute effects of coffee upon the risk of myocardial infarction: problems in the selection of a hospital control series. ( Kaufman, DW; Miettinen, OS; Rosenberg, L; Shapiro, S; Slone, D, 1981) |
| "The effect of consumption of caffeine-containing coffee on the risk of myocardial infarction in women 30-49 years of age was investigated." | 3.66 | Coffee drinking and myocardial infarction in young women. ( Kaufman, DW; Miettinen, OS; Rosenberg, L; Shapiro, S; Slone, D; Stolley, PD, 1980) |
| "Caffeine does not increase respiration in p27-deficient animals, whereas aged mice display improvement after 10 days of caffeine in drinking water." | 1.48 | CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system-New mode of action for caffeine. ( Abrams, M; Ale-Agha, N; Altschmied, J; Aufenvenne, K; Deenen, R; Dyballa-Rukes, N; Eckermann, O; Fischer, JW; Gonnissen, S; Gorressen, S; Goy, C; Grandoch, M; Haendeler, J; Jakob, S; Jakobs, P; Köhrer, K; Spannbrucker, T; Spyridopoulos, I; Unfried, K; von Ameln, F; Zurek, M, 2018) |
| "Caffeine is a nonspecific adenosine receptor blocker, and thus drinking CC may block the myocardial protective effects of statins." | 1.35 | Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. ( Abu Said, GH; Birnbaum, Y; Hughes, MG; Lin, Y; Manickavasagam, S; McAdoo, DJ; Perez-Polo, RJ; Ye, Y, 2008) |
| "Four caffeine-treated rats had histologic evidence of acute myocardial infarction which was not found in any of the other rats." | 1.26 | Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine. ( Johansson, S, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 41 (44.09) | 18.7374 |
| 1990's | 13 (13.98) | 18.2507 |
| 2000's | 28 (30.11) | 29.6817 |
| 2010's | 10 (10.75) | 24.3611 |
| 2020's | 1 (1.08) | 2.80 |
| Authors | Studies |
|---|---|
| Furtado, RHM | 1 |
| Venkateswaran, RV | 1 |
| Nicolau, JC | 2 |
| Gurmu, Y | 1 |
| Bhatt, DL | 1 |
| Storey, RF | 1 |
| Steg, PG | 1 |
| Magnani, G | 1 |
| Goto, S | 1 |
| Dellborg, M | 1 |
| Kamensky, G | 1 |
| Isaza, D | 1 |
| Aylward, P | 1 |
| Johanson, P | 1 |
| Bonaca, MP | 1 |
| Ale-Agha, N | 1 |
| Goy, C | 1 |
| Jakobs, P | 1 |
| Spyridopoulos, I | 1 |
| Gonnissen, S | 1 |
| Dyballa-Rukes, N | 1 |
| Aufenvenne, K | 1 |
| von Ameln, F | 1 |
| Zurek, M | 1 |
| Spannbrucker, T | 1 |
| Eckermann, O | 1 |
| Jakob, S | 1 |
| Gorressen, S | 1 |
| Abrams, M | 1 |
| Grandoch, M | 1 |
| Fischer, JW | 1 |
| Köhrer, K | 1 |
| Deenen, R | 1 |
| Unfried, K | 1 |
| Altschmied, J | 1 |
| Haendeler, J | 1 |
| Lohsoonthorn, V | 1 |
| Rattananupong, T | 1 |
| Wynne, K | 1 |
| Thomas, C | 1 |
| Chahal, HS | 1 |
| Berhane, HY | 1 |
| Mostofsky, E | 1 |
| Wuttithai, N | 1 |
| Gelaye, B | 1 |
| Øyehaug, L | 1 |
| Loose, KØ | 1 |
| Jølle, GF | 1 |
| Røe, ÅT | 1 |
| Sjaastad, I | 2 |
| Christensen, G | 1 |
| Sejersted, OM | 2 |
| Louch, WE | 1 |
| Johnsen, AB | 1 |
| Høydal, M | 1 |
| Røsbjørgen, R | 1 |
| Stølen, T | 1 |
| Wisløff, U | 1 |
| da Silva, JS | 1 |
| Pereira, SL | 1 |
| Maia, Rdo C | 1 |
| Landgraf, SS | 1 |
| Caruso-Neves, C | 1 |
| Kümmerle, AE | 1 |
| Fraga, CA | 1 |
| Barreiro, EJ | 1 |
| Sudo, RT | 1 |
| Zapata-Sudo, G | 1 |
| Mackiewicz, U | 1 |
| Maczewski, M | 1 |
| Konior, A | 1 |
| Tellez, JO | 1 |
| Nowis, D | 1 |
| Dobrzynski, H | 1 |
| Boyett, MR | 1 |
| Lewartowski, B | 1 |
| Reyes, E | 1 |
| Loong, CY | 1 |
| Harbinson, M | 1 |
| Donovan, J | 1 |
| Anagnostopoulos, C | 1 |
| Underwood, SR | 1 |
| Richardson, T | 1 |
| Baker, J | 1 |
| Thomas, PW | 1 |
| Meckes, C | 1 |
| Rozkovec, A | 1 |
| Kerr, D | 1 |
| Alpert, JS | 1 |
| Hirose, M | 1 |
| Stuyvers, BD | 1 |
| Dun, W | 1 |
| ter Keurs, HE | 1 |
| Boyden, PA | 3 |
| Banko, LT | 1 |
| Haq, SA | 1 |
| Rainaldi, DA | 1 |
| Klem, I | 1 |
| Siegler, J | 1 |
| Fogel, J | 1 |
| Sacchi, TJ | 1 |
| Heitner, JF | 1 |
| Biesmans, L | 1 |
| Macquaide, N | 1 |
| Heinzel, FR | 1 |
| Bito, V | 1 |
| Smith, GL | 2 |
| Sipido, KR | 1 |
| Belevych, AE | 1 |
| Terentyev, D | 1 |
| Terentyeva, R | 1 |
| Ho, HT | 1 |
| Gyorke, I | 1 |
| Bonilla, IM | 1 |
| Carnes, CA | 1 |
| Billman, GE | 1 |
| Györke, S | 1 |
| Floegel, A | 1 |
| Pischon, T | 1 |
| Bergmann, MM | 1 |
| Teucher, B | 1 |
| Kaaks, R | 1 |
| Boeing, H | 1 |
| Scott, MJ | 1 |
| El-Hassan, M | 1 |
| Khan, AA | 1 |
| Neary, P | 1 |
| Duncan, AM | 1 |
| Cobbe, SM | 1 |
| Bøkenes, J | 1 |
| Swift, F | 1 |
| Wasserstrom, JA | 1 |
| Tavani, A | 2 |
| Bertuzzi, M | 1 |
| Negri, E | 2 |
| Sorbara, L | 1 |
| La Vecchia, C | 3 |
| WENZEL, DG | 1 |
| MACCARTHY, JD | 1 |
| RUTLEDGE, CO | 1 |
| BAUMANN, W | 1 |
| Myers, MG | 3 |
| Mukamal, KJ | 1 |
| Maclure, M | 1 |
| Muller, JE | 1 |
| Sherwood, JB | 1 |
| Mittleman, MA | 1 |
| Happonen, P | 2 |
| Voutilainen, S | 2 |
| Salonen, JT | 2 |
| Nyska, A | 1 |
| Murphy, E | 1 |
| Foley, JF | 1 |
| Collins, BJ | 1 |
| Petranka, J | 1 |
| Howden, R | 1 |
| Hanlon, P | 1 |
| Dunnick, JK | 1 |
| Sudano, I | 2 |
| Binggeli, C | 1 |
| Spieker, L | 1 |
| Lüscher, TF | 1 |
| Ruschitzka, F | 1 |
| Noll, G | 1 |
| Corti, R | 2 |
| Solenkova, NV | 1 |
| Solodushko, V | 1 |
| Cohen, MV | 1 |
| Downey, JM | 1 |
| Rempher, KJ | 1 |
| Azevedo, A | 1 |
| Barros, H | 1 |
| Baylin, A | 2 |
| Hernandez-Diaz, S | 1 |
| Kabagambe, EK | 2 |
| Siles, X | 1 |
| Campos, H | 2 |
| Siscovick, DS | 1 |
| Perez, GH | 1 |
| Romano, BW | 1 |
| Laranjeira, R | 1 |
| Tuomainen, TP | 1 |
| Flammer, AJ | 1 |
| Culić, V | 1 |
| Poole, C | 1 |
| Ye, Y | 1 |
| Abu Said, GH | 1 |
| Lin, Y | 1 |
| Manickavasagam, S | 1 |
| Hughes, MG | 1 |
| McAdoo, DJ | 1 |
| Perez-Polo, RJ | 1 |
| Birnbaum, Y | 1 |
| Riksen, NP | 1 |
| Hausenloy, DJ | 1 |
| Yellon, DM | 1 |
| Johansson, S | 1 |
| Curatolo, PW | 1 |
| Robertson, D | 1 |
| James, JE | 1 |
| Stirling, KP | 1 |
| Rosenberg, L | 5 |
| Slone, D | 2 |
| Shapiro, S | 5 |
| Kaufman, DW | 4 |
| Miettinen, OS | 2 |
| Stolley, PD | 1 |
| Palmer, JR | 2 |
| Rao, RS | 1 |
| D'Avanzo, B | 1 |
| Franceschi, S | 2 |
| Gentile, A | 1 |
| Boutjdir, M | 2 |
| Assadi, M | 1 |
| el-Sherif, N | 2 |
| Willett, WC | 1 |
| Stampfer, MJ | 1 |
| Manson, JE | 1 |
| Colditz, GA | 1 |
| Rosner, BA | 1 |
| Speizer, FE | 1 |
| Hennekens, CH | 2 |
| Forman, J | 1 |
| Aizer, A | 1 |
| Young, CR | 1 |
| Yamaguchi, F | 1 |
| Sanbe, A | 1 |
| Takeo, S | 1 |
| Rosenkranz, S | 1 |
| Deutsch, HJ | 1 |
| Erdmann, E | 1 |
| Zhang, XQ | 2 |
| Musch, TI | 2 |
| Zelis, R | 1 |
| Cheung, JY | 2 |
| Ng, YC | 1 |
| Moore, RL | 1 |
| Smith, IK | 1 |
| Pu, J | 1 |
| Robinson, RB | 1 |
| Hemzacek, KI | 1 |
| Furlong, FW | 1 |
| MacCornack, FA | 1 |
| Heyden, S | 4 |
| Tyroler, HA | 1 |
| Cassel, JC | 1 |
| Hames, CG | 1 |
| Becker, C | 1 |
| Heiss, G | 1 |
| Johnson, RB | 1 |
| McCance, DM | 1 |
| Lukash, WM | 1 |
| Al-Samarrae, W | 1 |
| Ma, MC | 1 |
| Truswell, AS | 1 |
| Vaisrub, S | 1 |
| Wolff, G | 1 |
| Drolette, ME | 1 |
| Jesse, MJ | 1 |
| Davies, JE | 1 |
| Hutchison, GB | 1 |
| Harris, L | 2 |
| Grobbee, DE | 1 |
| Rimm, EB | 1 |
| Giovannucci, E | 1 |
| Colditz, G | 1 |
| Stampfer, M | 1 |
| Willett, W | 1 |
| Gough, WB | 1 |
| Klatsky, AL | 1 |
| Friedman, GD | 1 |
| Armstrong, MA | 1 |
| Leenen, FH | 1 |
| Grant, DM | 1 |
| Thandroyen, FT | 1 |
| McCarthy, J | 1 |
| Burton, KP | 1 |
| Opie, LH | 1 |
| Gardner, PI | 1 |
| Wit, AL | 1 |
| Schneider, JR | 2 |
| Kelly, JP | 1 |
| Decarli, A | 1 |
| Pampallona, S | 1 |
| Tognoni, G | 1 |
| Werler, MM | 1 |
| Kaneko, N | 1 |
| Takeishi, M | 1 |
| Steinke, J | 1 |
| Bonk, S | 1 |
| Stocksmeier, U | 1 |
| Surawicz, B | 1 |
| Escher, M | 1 |
| Fica, V | 1 |
| Panaitescu, G | 1 |
| Mătrescu, F | 1 |
| Haldeman, J | 1 |
| Olson, PT | 1 |
| Heinonen, OP | 1 |
| Schneider, JA | 1 |
| Sperelakis, N | 1 |
| Guy-Grand, B | 1 |
| Dorf, G | 1 |
| Duchier, J | 1 |
| Aimez, P | 1 |
| Bellet, S | 1 |
| Horstmann, E | 1 |
| Roman, LR | 1 |
| DeGuzman, NT | 1 |
| Kostis, JB | 1 |
| Capri, C | 1 |
| Sturm, A | 1 |
| Scheja, HW | 1 |
| Puentes, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myoca[NCT01225562] | Phase 3 | 21,379 participants (Actual) | Interventional | 2010-10-31 | Completed | ||
| Evaluation of Energy Drink Consumption on Electrocardiographic, Vascular and Hematologic Parameters in Young Healthy Volunteers: A Randomized, Double Blind, Active-Controlled, Crossover Study[NCT03021616] | 2 participants (Actual) | Interventional | 2017-06-26 | Terminated (stopped due to Results from sister study at University of the Pacific were conclusive.) | |||
| [NCT00005243] | 0 participants | Observational | 1989-04-30 | Completed | |||
| Evaluation of the Effect of Espresso on Platelet Aggregability in Patients With Coronary Artery Disease[NCT04827251] | 30 participants (Anticipated) | Interventional | 2019-03-18 | Recruiting | |||
| [NCT03308838] | 4,547 participants (Actual) | Observational | 1994-08-01 | Completed | |||
| The Effect of Metabolism-Boosting Beverages on 24 Hr Energy Expenditure[NCT01029236] | 30 participants (Actual) | Interventional | 2007-06-30 | Completed | |||
| [NCT00005185] | 0 participants | Observational | 1986-04-30 | Completed | |||
| Nurses' Health Study (Cardiovascular Component)[NCT00005152] | 121,700 participants (Actual) | Observational | 1980-08-31 | Active, not recruiting | |||
| [NCT00005122] | 0 participants | Observational | 1958-07-31 | Completed | |||
| [NCT00005182] | 50,000 participants (Actual) | Observational | 1985-12-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Participants with death from any cause. If no event, censoring occurs at the earliest of the efficacy cut-off date 14 Sep 2014, withdrawal of consent or the last time point the particapant was known to be alive. Events were adjudicated by a blinded endpoint committee. The Kaplan-Meier estimate reports the percentage of patients who died from any cause within 3 years from randomization (NCT01225562)
Timeframe: Randomization up to 47 months
| Intervention | Percentage of Patients (Number) |
|---|---|
| Ticagrelor 90 mg | 5.1 |
| Ticagrelor 60 mg | 4.7 |
| Placebo | 5.2 |
A Thrombolysis in Myocardial Infarction (TIMI) study group major bleeding is defined as any fatal bleeding (leading directly to death within 7 days), any intrcranial bleeding or any clinically overt signs of haemorrhage associated with a drop in Haemoglobin of >= 5g/dL. Events were adjudicated by a clinical events committee. Censoring ocurrs at 7 days following last dose of study drug. The Kaplan-Meier estimate reports the percentage of patients who experienced a TIMI Major bleeding within 3 years from first dose of study drug (NCT01225562)
Timeframe: First dosing up to 48 months
| Intervention | Percentage of Patients (Number) |
|---|---|
| Ticagrelor 90 mg | 2.6 |
| Ticagrelor 60 mg | 2.3 |
| Placebo | 1.1 |
Participants with CV death. If no event, censoring occurs at the earliest of the efficacy cut-off date 14 Sep 2014, withdrawal of consent, non-CV death or at the last time point of complete clinical event assessment. Events were adjudicated by a blinded endpoint committee. The Kaplan-Meier estimate reports the percentage of patients who experienced CV Death within 3 years from randomization (NCT01225562)
Timeframe: Randomization up to 47 months
| Intervention | Percentage of Patients (Number) |
|---|---|
| Ticagrelor 90 mg | 2.9 |
| Ticagrelor 60 mg | 2.9 |
| Placebo | 3.4 |
Participants with CV death, MI or Stroke. If no event, censoring occurs at the earliest of the efficacy cut-off date 14 Sep 2014, withdrawal of consent, non-CV death or at the last time point of complete clinical event assessment. Events were adjudicated by a blinded endpoint committee. The Kaplan-Meier estimate reports the percentage of patients who experienced CV Death, MI or stroke within 3 years from randomization (NCT01225562)
Timeframe: Randomization up to 47 months
| Intervention | Percentage of Patients (Number) |
|---|---|
| Ticagrelor 90 mg | 7.8 |
| Ticagrelor 60 mg | 7.8 |
| Placebo | 9.0 |
7 reviews available for caffeine and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardiovascular effects of coffee: is it a risk factor?
Topics: Blood Glucose; Caffeine; Cardiovascular System; Coffee; Cooking; Diabetes Mellitus, Type 1; Drinking | 2005 |
Cardiovascular sequelae of tobacco smoking.
Topics: Aortic Aneurysm, Abdominal; Arrhythmias, Cardiac; Atherosclerosis; Caffeine; Cardiovascular Diseases | 2006 |
The health consequences of caffeine.
Topics: Brain; Caffeine; Coffee; Digestive System; Drug Tolerance; Female; Fibrocystic Breast Disease; Hemod | 1983 |
Caffeine: a survey of some of the known and suspected deleterious effects of habitual use.
Topics: Abnormalities, Drug-Induced; Anxiety Disorders; Behavior Therapy; Caffeine; Coffee; Diagnosis, Diffe | 1983 |
Possible psychiatric significance of excessive coffee consumption.
Topics: Adult; Anxiety Disorders; Blood Pressure; Caffeine; Canada; Cardiovascular System; Cerebrovascular C | 1975 |
Should patients with myocardial infarction receive caffeinated coffee?
Topics: Adult; Aged; Caffeine; Coffee; Female; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarctio | 1988 |
[Coffee-drinking from the medical point of view].
Topics: Adult; Blood Pressure; Caffeine; Coffee; Diabetes Mellitus; Feeding Behavior; Female; Gout; Health S | 1973 |
6 trials available for caffeine and Cardiovascular Stroke
| Article | Year |
|---|---|
Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial.
Topics: Aged; Aspirin; Beverages; Caffeine; Double-Blind Method; Dual Anti-Platelet Therapy; Dyspnea; Female | 2020 |
Randomized control trial investigating the influence of coffee on heart rate variability in patients with ST-segment elevation myocardial infarction.
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Caffeine; Coffee; Double-Blind Method; Electro | 2009 |
Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening.
Topics: Aged; Caffeine; Coronary Disease; Dipyridamole; Drug Interactions; Exercise Test; Female; Hemodynami | 2010 |
High dose caffeine and ventricular arrhythmias.
Topics: Aged; Arrhythmias, Cardiac; Caffeine; Cardiac Complexes, Premature; Clinical Trials as Topic; Coffee | 1990 |
Caffeine as a possible cause of ventricular arrhythmias during the healing phase of acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Blood Pressure; Caffeine; Cardiac Complexes, Premature; Double-Blind Method; E | 1987 |
Effects of caffeine ingestion on heart rate, blood pressure, myocardial oxygen consumption, and cardiac rhythm in acute myocardial infarction patients.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Caffeine; Coronary Care Units; Double-Blind Method; | 1987 |
80 other studies available for caffeine and Cardiovascular Stroke
| Article | Year |
|---|---|
CDKN1B/p27 is localized in mitochondria and improves respiration-dependent processes in the cardiovascular system-New mode of action for caffeine.
Topics: Adenosine Triphosphate; Animals; Apoptosis; Caffeine; Cardiotonic Agents; Cell Differentiation; Cell | 2018 |
Immediate risk of myocardial infarction following physical exertion, tea, and coffee: A case-crossover study in Thailand.
Topics: Aged; Caffeine; Case-Control Studies; Coffee; Cross-Over Studies; Female; Humans; Male; Middle Aged; | 2019 |
Synchrony of cardiomyocyte Ca(2+) release is controlled by T-tubule organization, SR Ca(2+) content, and ryanodine receptor Ca(2+) sensitivity.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Signaling; Cytosol; Female; Mice; Mice | 2013 |
Aerobic interval training partly reverse contractile dysfunction and impaired Ca2+ handling in atrial myocytes from rats with post infarction heart failure.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Cardiotonic Agents; Electric Stimulation; Exercise Th | 2013 |
N-acylhydrazone improves exercise intolerance in rats submitted to myocardial infarction by the recovery of calcium homeostasis in skeletal muscle.
Topics: Animals; Caffeine; Calcium; Disease Models, Animal; Exercise Tolerance; Homeostasis; Hydrazones; Mal | 2014 |
Sarcolemmal Ca2+-ATPase ability to transport Ca2+ gradually diminishes after myocardial infarction in the rat.
Topics: Animals; Caffeine; Calcium; Calcium Signaling; Disease Models, Animal; Down-Regulation; Electric Sti | 2009 |
High-dose adenosine overcomes the attenuation of myocardial perfusion reserve caused by caffeine.
Topics: Adenosine; Aged; Caffeine; Central Nervous System Stimulants; Coffee; Coronary Artery Disease; Coron | 2008 |
"Hey, doc, is it OK for me to drink coffee?".
Topics: Blood Pressure; Caffeine; Central Nervous System Stimulants; Cholesterol; Coffee; Humans; Myocardial | 2009 |
Function of Ca(2+) release channels in Purkinje cells that survive in the infarcted canine heart: a mechanism for triggered Purkinje ectopy.
Topics: Animals; Arrhythmias, Cardiac; Caffeine; Calcium Channels; Calcium Signaling; Cell Survival; Disease | 2008 |
Subcellular heterogeneity of ryanodine receptor properties in ventricular myocytes with low T-tubule density.
Topics: Animals; Caffeine; Calcium Signaling; Cells, Cultured; Heart Ventricles; Models, Biological; Myocard | 2011 |
Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death.
Topics: Adrenergic beta-Agonists; Animals; Benzylamines; Caffeine; Calcium Channel Agonists; Calcium Signali | 2012 |
Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Germany study.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Coffee; Cohort Studies; Diabetes Mellitus, Type 2; F | 2012 |
Myocardial infarction in a young adult following the consumption of a caffeinated energy drink.
Topics: Caffeine; Energy Drinks; Humans; Male; Myocardial Infarction; Young Adult | 2011 |
Assessment of sarcoplasmic reticulum Ca(2+) flux pathways in cardiomyocytes from rabbits with infarct-induced left-ventricular dysfunction.
Topics: Animals; Biological Transport; Caffeine; Calcium; Calcium-Transporting ATPases; Disease Models, Anim | 2002 |
Normal contractions triggered by I(Ca,L) in ventricular myocytes from rats with postinfarction CHF.
Topics: Action Potentials; Animals; Caffeine; Calcium; Calcium Channels, L-Type; Calcium-Binding Proteins; C | 2002 |
Alcohol, smoking, coffee and risk of non-fatal acute myocardial infarction in Italy.
Topics: Adult; Aged; Alcohol Drinking; Caffeine; Case-Control Studies; Chi-Square Distribution; Coffee; Fema | 2001 |
EVALUATION OF CAFFEINE AND OUABAIN AS PERMISSIVE AGENTS IN THE PRODUCTION OF MYOCARDIAL NECROSIS.
Topics: Animals; Blood Coagulation; Blood Pressure; Caffeine; Cholesterol; Hypercholesterolemia; Myocardial | 1964 |
[On the pathogenesis and therapy of myocardial infarct, with special reference to the author's experience with injections of impletol and strophanthin].
Topics: Caffeine; Coronary Disease; Drug Combinations; Humans; Myocardial Infarction; Procaine; Strophanthin | 1951 |
Effect of caffeine on blood pressure beyond the laboratory.
Topics: Adult; Age Factors; Beverages; Blood Pressure; Caffeine; Capsules; Clinical Trials as Topic; Drug Ad | 2004 |
Caffeinated coffee consumption and mortality after acute myocardial infarction.
Topics: Aged; Alcohol Drinking; Caffeine; Carbonated Beverages; Coffee; Cohort Studies; Comorbidity; Diabete | 2004 |
Coffee drinking is dose-dependently related to the risk of acute coronary events in middle-aged men.
Topics: Adult; Caffeine; Central Nervous System Stimulants; Coffee; Cohort Studies; Cooking; Diet Records; D | 2004 |
Acute hemorrhagic myocardial necrosis and sudden death of rats exposed to a combination of ephedrine and caffeine.
Topics: Acute Disease; Administration, Oral; Adrenergic Agents; Animals; Caffeine; Caspase 3; Caspases; Cent | 2005 |
Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt.
Topics: Acetamides; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Antagonists; Androstadienes; An | 2006 |
Coffee and myocardial infarction: heterogeneity of an association in Portuguese men.
Topics: Adult; Body Size; Caffeine; Coffee; Energy Intake; Humans; Male; Myocardial Infarction; Portugal; Ri | 2006 |
Transient exposure to coffee as a trigger of a first nonfatal myocardial infarction.
Topics: Acute Disease; Aged; Caffeine; Central Nervous System Stimulants; Coffee; Costa Rica; Cross-Over Stu | 2006 |
Triggers of clinical coronary heart disease.
Topics: Acute Disease; Caffeine; Central Nervous System Stimulants; Humans; Myocardial Infarction; Reproduci | 2006 |
Smoking-associated factors in myocardial infarction and unstable angina: do gender differences exist?
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Angina, Unstable; Attitude; Caffeine; Drinking Behavior | 2007 |
Catechol-o-methyltransferase gene polymorphism modifies the effect of coffee intake on incidence of acute coronary events.
Topics: Adult; Aged; Base Sequence; Caffeine; Catechol O-Methyltransferase; Catecholamines; Coffee; Cohort S | 2006 |
Coffee and myocardial infarction.
Topics: Blood Pressure; Caffeine; Case-Control Studies; Central Nervous System Stimulants; Coffee; Feeding B | 2007 |
Coffee and myocardial infarction.
Topics: Caffeine; Central Nervous System Stimulants; Coffee; Confounding Factors, Epidemiologic; Eating; Fee | 2007 |
Nonfatal acute myocardial infarction in Costa Rica: modifiable risk factors, population-attributable risks, and adherence to dietary guidelines.
Topics: Abdominal Fat; Adult; Aged; Caffeine; Case-Control Studies; Costa Rica; Diet; Female; Guidelines as | 2007 |
Coffee and myocardial infarction.
Topics: Caffeine; Coffee; Cross-Over Studies; Humans; Myocardial Infarction; Odds Ratio; Time Factors | 2007 |
Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat.
Topics: Administration, Oral; Animals; Atorvastatin; Blood Pressure; Caffeine; Coffee; Disease Models, Anima | 2008 |
Wake up and smell the coffee: yet another no go for cardiac patients? : editorial to "caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat" by Ye et al.
Topics: Administration, Oral; Animals; Atorvastatin; Caffeine; Coffee; Food-Drug Interactions; Heptanoic Aci | 2008 |
Cardiovascular lesions in Sprague-Dawley rats induced by long-term treatment with caffeine.
Topics: Acetaminophen; Animals; Antipyrine; Caffeine; Cardiovascular Diseases; Heart; Male; Myocardial Infar | 1981 |
Case-control studies on the acute effects of coffee upon the risk of myocardial infarction: problems in the selection of a hospital control series.
Topics: Acute Disease; Adult; Caffeine; Chronic Disease; Coffee; Feeding Behavior; Female; Hospitalization; | 1981 |
Coffee drinking and myocardial infarction in young women.
Topics: Acute Disease; Adult; Caffeine; Coffee; Epidemiologic Methods; Female; Humans; Middle Aged; Myocardi | 1980 |
Coffee consumption and myocardial infarction in women.
Topics: Aged; Angina Pectoris; Caffeine; Case-Control Studies; Coffee; Female; Humans; Hypertension; Logisti | 1995 |
Decaffeinated coffee and acute myocardial infarction. A case-control study in Italian women.
Topics: Adult; Aged; Caffeine; Case-Control Studies; Coffee; Female; Humans; Italy; Middle Aged; Myocardial | 1993 |
Electrophysiologic effects of cocaine on subendocardial Purkinje fibers surviving 1 day of myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Caffeine; Calcium; Central Nervous System S | 1995 |
Coffee consumption and coronary heart disease in women. A ten-year follow-up.
Topics: Adult; Caffeine; Coffee; Coronary Disease; Female; Follow-Up Studies; Humans; Middle Aged; Multivari | 1996 |
Myocardial infarction resulting from caffeine overdose in an anorectic woman.
Topics: Adult; Bulimia; Caffeine; Central Nervous System Stimulants; Drug Overdose; Female; Humans; Myocardi | 1997 |
Cardiac sarcoplasmic reticular function in rats with chronic heart failure following myocardial infarction.
Topics: Animals; Caffeine; Calcium; Cell Membrane; Central Nervous System Stimulants; Heart Failure; Hemodyn | 1997 |
[33-year-old patient with postpartum myocardial infarct].
Topics: Adult; Aminopyrine; Caffeine; Coronary Angiography; Coronary Thrombosis; Coronary Vasospasm; Drug Co | 1997 |
Effects of impaired Ca2+ homeostasis on contraction in postinfarction myocytes.
Topics: Animals; Caffeine; Calcium; Calcium Channels; Central Nervous System Stimulants; Electric Stimulatio | 1999 |
In situ SR function in postinfarction myocytes.
Topics: Animals; Caffeine; Calcium; Calcium-Transporting ATPases; Cell Membrane Permeability; Heart; Intrace | 1999 |
Trouble brewing. A steaming cup is a great comfort, but consider the effects of unfiltered coffee on the heart.
Topics: Caffeine; Coffee; Heart; Humans; Myocardial Infarction | 2000 |
Abnormalities in Ca(i)handling in myocytes that survive in the infarcted heart are not just due to alterations in repolarization.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Cells, Cultured; Central Nervous System Stimul | 2000 |
Dietary protocol for the patient who has suffered a myocardial infarction.
Topics: Caffeine; Cardiovascular Diseases; Cholesterol, Dietary; Feeding Behavior; Humans; Menu Planning; My | 1978 |
The effects of coffee drinking on the cardiovascular system: experimental and epidemiological research.
Topics: Adolescent; Adult; Aged; Blood Pressure; Caffeine; Cardiovascular System; Chlorogenic Acid; Coffee; | 1977 |
Coffee and cardiovascular disease.
Topics: Acute Disease; Beverages; Caffeine; Cardiovascular Diseases; Coffee; Heart Rate; Humans; Male; Myoca | 1977 |
Coffee consumption and mortality in a community study--Evans Co., Ga.
Topics: Black People; Caffeine; Cerebrovascular Disorders; Coffee; Coronary Disease; Female; Georgia; Habits | 1976 |
Coffee treat or trick?
Topics: Adult; Caffeine; Coffee; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Humans; Infant, Newborn; Myo | 1975 |
Methylxanthine consumption from coffee and tea.
Topics: Caffeine; Coffee; Myocardial Infarction; Tea; Theobromine; Xanthines | 1975 |
Editorial: A break for the coffee-break.
Topics: Adult; Aged; Caffeine; Coffee; Coronary Disease; Death, Sudden; Heart; Hemodynamics; Humans; Male; M | 1975 |
[Coffee from medical point of view].
Topics: Caffeine; Coffee; Energy Metabolism; Humans; Hypertension; Mutagens; Myocardial Infarction | 1975 |
Coffee drinking and death due to coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Body Weight; Caffeine; Coffee; Coronary Disease; Diabetes Complication | 1976 |
Coffee, caffeine, and cardiovascular disease in men.
Topics: Adult; Aged; Caffeine; Cardiovascular Diseases; Cerebrovascular Disorders; Coffee; Coronary Disease; | 1990 |
Effects of caffeine and ryanodine on delayed afterdepolarizations and sustained rhythmic activity in 1-day-old myocardial infarction in the dog.
Topics: Alkaloids; Animals; Caffeine; Dogs; Electrophysiology; Myocardial Infarction; Osmolar Concentration; | 1990 |
Coffee use prior to myocardial infarction restudied: heavier intake may increase the risk.
Topics: Aged; Alcohol Drinking; Blood Glucose; Blood Pressure; Caffeine; California; Cholesterol; Coffee; Ep | 1990 |
Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart.
Topics: Alkaloids; Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Coronary Circulation; Cyclic AMP; Energ | 1988 |
Action potentials of cardiac muscle in healing infarcts: response to norepinephrine and caffeine.
Topics: Action Potentials; Animals; Caffeine; Cyclic AMP; Dogs; Heart; Isotonic Solutions; Membrane Potentia | 1988 |
Coffee drinking and nonfatal myocardial infarction in men under 55 years of age.
Topics: Adult; Caffeine; Coffee; Humans; Male; Middle Aged; Myocardial Infarction; Smoking; Tea; Time Factor | 1988 |
Risk factors for myocardial infarction in young women.
Topics: Adult; Caffeine; Contraceptives, Oral; Diabetes Complications; Epidemiologic Methods; Family; Female | 1987 |
Coffee drinking and myocardial infarction in young women: an update.
Topics: Adult; Caffeine; Female; Humans; Middle Aged; Myocardial Infarction; Smoking | 1987 |
New theory on the pathogenesis of acute myocardial infarction.
Topics: Adult; Aged; Animals; Caffeine; Calcium; Cell Survival; Coronary Vessels; Dogs; Electrocardiography; | 1986 |
Coffee drinking and acute myocardial infarction.
Topics: Acute Disease; Adult; Caffeine; Coffee; Humans; Lipids; Myocardial Infarction | 1973 |
[Do correlations exist between coffee drinking and myocardial infarction? (author's transl)].
Topics: Adolescent; Adult; Aged; Caffeine; Coffee; Female; Food Preferences; Germany, West; Health Surveys; | 1974 |
Editorial: Calcium responses ("calcium spikes").
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Coronary Disease; Cyclic AMP; E | 1974 |
[Effects of coffee during good health and in disease from the medical standpoint].
Topics: Acute Disease; Aged; Blood Pressure; Caffeine; Cerebrovascular Disorders; Coffee; Diabetes Mellitus; | 1974 |
[General and specific circumstances in pathogenesis of paroxysmal tachycardias].
Topics: Acid-Base Equilibrium; Caffeine; Catecholamines; Digitalis Glycosides; Electrolytes; Fatty Acids; He | 1972 |
Letter: Coffee and myocardial infarction.
Topics: Caffeine; Coffee; Humans; Myocardial Infarction; Personality; Tea | 1973 |
Classes for coronary care patients.
Topics: Caffeine; Cholesterol, Dietary; Coronary Disease; Diet Therapy; Dietary Fats; Myocardial Infarction; | 1973 |
[Coffee and coronary disease].
Topics: Acute Disease; Caffeine; Coffee; Coronary Disease; Fibrinolysis; Humans; Myocardial Infarction | 1973 |
The demonstration of energy dependence of the isoproterenol-induced transcellular Ca2+ current in isolated perfused guinea pig hearts--an explanation for mechanical failure of ischemic myocardium.
Topics: Action Potentials; Animals; Biological Transport; Caffeine; Calcium; Cell Membrane; Cell Membrane Pe | 1974 |
[Dietetics and nutrition in 1972].
Topics: Adipose Tissue; Alcoholic Intoxication; Anorexia Nervosa; Caffeine; Calcium; Catecholamines; Coffee; | 1972 |
Effect of caffeine on the ventricular fibrillation threshold in normal dogs and dogs with acute myocardial infarction.
Topics: Animals; Benzoates; Caffeine; Dogs; Heart; Myocardial Infarction; Propranolol; Sodium; Ventricular F | 1972 |
[Coffee consumption and myocardial infarct].
Topics: Caffeine; Catecholamines; Cholesterol; Coffee; Humans; Lipid Metabolism; Myocardial Infarction | 1969 |
[Differential diagnosis of increased catecholamine excretion in arterial hypertension].
Topics: Adrenal Gland Neoplasms; Adrenal Glands; Arteries; Asthma; Caffeine; Catecholamines; Diagnosis, Diff | 1970 |
[The BBC study. Applied epidemiology of ischemic heart diseases].
Topics: Adult; Body Weight; Caffeine; Cholesterol; Coronary Disease; Epidemiologic Methods; Hematocrit; Huma | 1967 |